Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries
Madeddu, G., Vroling, H., Oordt-Speets, A., Babudieri, S., O'Moore, É., Noordegraaf, M.V., Monarca, R., Lopalco, P.L., Hedrich, D., Tavoschi, L.
Surveillance systems overview for 2017
This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2017.
- Chikungunya virus disease
- Chlamydia infection
- Crimean-Congo haemorrhagic fever
- Ebola haemorrhagic fever
- Hantavirus infection
- Healthcare-associated infections
- Hepatitis A
- Hepatitis B
- Hepatitis C
- HIV infection
- Invasive Haemophilus influenzae disease
- Lassa fever
- Marburg haemorrhagic fever
- Meningococcal disease
- Pneumococcal disease
- Q fever
- Rift Valley fever
- Severe acute respiratory syndrome (SARS)
- Surgical site infections
- Verotoxigenic Escherichia coli infection
- West Nile virus infection
- Yellow fever
Public health guidance on prevention and control of blood-borne viruses in prison settings
This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.
Guidance in brief: Prevention and control of blood-borne viruses in prison settings
This guidance is intended for policymakers responsible for the planning and delivery of healthcare services in the national or sub-national custodial system and all professionals responsible for the health and well-being of people in prison, including community-based service providers and those facilitating continuity of care in the community.
Systematic review on the prevention and control of blood-borne viruses in prison settings
The objective of this report was to systematically review data on prevention and control of BBVs in prison settings, with a focus on the countries of the European Union (EU) and the European Economic Area (EEA).
Public health guidance on active case finding of communicable diseases in prison settings
This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.
Communicable disease threats report, 9-15 April 2017, week 15
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 April 2017 and includes updates on hepatitis A, influenza, MDR TB, measles, yellow fever, Zika, dengue and Chikungunya.
Communicable disease threats report, 2–8 April 2017, week 14
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2–8 April 2017 and includes updates on influenza, MDR TB and Measles.
Communicable disease threats report 18-24 Dec 2016, week 51
This ECDC Communicable Disease Threats Report covers 18-24 December 2016 and includes updates on Salmonella Stourbridge, type E botulism, hepatitis A, tuberculosis, cholera, influenza, measles, rubella, Legionnaires' disease and the Zika virus.